Amazon.com Inc. Message Board
-
true, why earnings matter for a 20-y/o company with a mkt cap of over $125Billion?
/end_of_sarcasm -
time to short!
-
no halt, the CHMP meeting minutes are typically out early in the morning (~noon time UK)
-
shorts earned this!!!
- Reply to
Any of you guys ever witness a short squeeze of the magnitude possible with ARNA?
by smit3413 •Apr 23, 2013 12:47 AMDNDN from $4.50 to $10 overnight and then to $30 within 3 weeks post adcom 2007 .... then the FDA/shrts/dcotors crooks derailed it. You may want to google "deep capture dendreon" and read the full 15-chapters story. Many ARNA old-timers were/are on the DNDN's roller-coaster. You can also try to order a book about this case via Amazon but current shipping time is over a month.
- Reply to
New FInancial Times article- Mystery Objectors Delay Weight Loss Drug
by todzun •Apr 21, 2013 8:12 PMwondering why people are DIS-liking this article (except the fact that this story has been posted on the MB 2+ hours ago)
-
the author missed the "Wesley Day" neg post
-
from investors village MB, quoting the a document posted today by the DEA: "MOST IMPORTANT is that the BOTTOM LINE is clearly unchanged and can be paraphrased as "Lorc has a lower abuse potential vis-a-vis other sked-3 drug while it is in line with the abuse risks associated with sked-4 drugs"
- Reply to
DEA Posting Date vs Document Signature Date for Scheduled Drugs
by tschussmann •Apr 4, 2013 8:51 PMinteresting, thanks!
-
I expect that another 1-2 analysts will follow by the end of next week. This was actually a brave call, usually,analysts call the mega-bubbles only AFTER they burst. AMZN has stiff competition in eachand every market that they are in. No question that they will collapse like a house of cards.
"The King in Naked!" -
... and they've missed this one as well but 35% or so ... will be interesting to hear the pumperlysts spinning this mega-miss (from $12m to $2M, wow!)
-
Reducing revenue est by 75% is BIG .... Did CS cut their price-target accordingly?
-
Here is the source --- Seeking Alpha Nov. 17, 2012: "Vivus Inc: This Hedge Fund Just Went Activist" ... so if one carefully reads article:
QUOTE FROM THE ARTICLE --- " ... Talk of selling the company comes along with highly promissory analyst comments-Credit Suisse analyst Lee Kalowski claims that the company will deliver $12 million in revenue for the fourth quarter 2012. Though Kalowski has an outperform rating on the stock, his revenue estimates for the drug are at around half that of consensus analyst estimates..." -
Check Seeking Alpha Nov. 17, 2012: "Vivus Inc: This Hedge Fund Just Went Activist" ... now go deep into this article:
" ... Talk of selling the company comes along with highly promissory analyst comments-Credit Suisse analyst Lee Kalowski claims that the company will deliver $12 million in revenue for the fourth quarter 2012. Though Kalowski has an outperform rating on the stock, his revenue estimates for the drug are at around half that of consensus analyst estimates..." -